Daniel Watterson to Pandemics
This is a "connection" page, showing publications Daniel Watterson has written about Pandemics.
Connection Strength
0.004
-
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis. 2021 10; 21(10):1383-1394.
Score: 0.002
-
Assessing the potential of unmanned aerial vehicle spraying of aqueous ozone as an outdoor disinfectant for SARS-CoV-2. Environ Res. 2021 05; 196:110944.
Score: 0.002